Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|February 1, 1999

Kodak's Q4 sales benefit from Imation

Kodak's Q4 sales benefit from ImationEastman Kodak's aquisition of Imation's medical imaging business is already yielding dividends. The Rochester, NY, company's Health Imaging segment reported net earnings for its fourth quarter (end-December)

Kodak's Q4 sales benefit from Imation

Eastman Kodak's aquisition of Imation's medical imaging business is already yielding dividends. The Rochester, NY, company's Health Imaging segment reported net earnings for its fourth quarter (end-December) of $28 million, which included a $30 million after-tax charge linked to the Imation purchase (PNN 1/99).

Sales for the quarter were $442 million, up $46 million because of the Imation acquisition. The Health Imaging division's full-year net earnings were $205 million, as compared with last year's $213 million.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.